Therapeutic Botox® (Botulinum Toxin Type A) is FDA approved for chronic mirgranes, cervical dystonia (wry neck), strabismus (crossed eyes) and blepharospasm (twitching of the eyelids), and spasticity (Muscle Contractions). Botox® has also been successfully used for pain, chronic migraines and spasticity.

Frequently asked questions about BOTOX®

Is BOTOX® Cosmetic the same as BOTOX® neurotoxin?

Yes. BOTOX® neurotoxin is one of the most widely researched medicines in the world and has been used for approximately 20 years. The same formulation with dosing specific for moderate to severe glabellar lines (stubborn frown lines between the brows) for people ages 18 to 65 was approved in 2002 as BOTOX® Cosmetic.

Is it safe to get repeated injections of BOTOX®?

Yes. Patients around the world receive repeated injections of BOTOX® neurotoxin to effectively treat a variety of medical conditions (cervical dystonia, blepharospam, and strabismus).

Do patients always have the same response to repeated BOTOX® injections?

No. There are many factors that can impact the results of BOTOX® treatment. A small percentage of people develop immunity to BOTOX®. Other factors that impact results include the accuracy of injections, dosing and changes in patients’ conditions over time.

Are all botulinum toxins the same as BOTOX® treatment?

No. No two botulinum toxin products are the same. They differ in dosing, manufacturing process, potency, and adverse events. As a result, each product and its unit dosing is unique and different, and one product cannot take the place of another.